The Molecularly Long-chain Fatty Acid Oxidation Disorders Market addresses a group of rare, inherited metabolic conditions where the body cannot efficiently break down long-chain fatty acids into energy, particularly during periods of fasting or illness. These disorders, which include Very Long-Chain Acyl-CoA Dehydrogenase (VLCAD) deficiency and Long-chain 3-Hydroxyacyl-CoA Dehydrogen... https://shashikant873.livejournal.com/3767.html